A brand of recalled heart failure and blood pressure medication was found to have a second, carcinogenic impurity.
The U.S. Food and Drug Administration (FDA) said that three lots of Torrent Pharmaceuticals’ valsartan drugs have NDEA, known to cause cancer in animals and is believed to be carcinogenic to humans, according to a statement on Sept. 13.
